{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:08:28Z","timestamp":1791230908933,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.biomaterials.2008.10.003","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T20:08:10Z","timestamp":1226088490000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells"],"prefix":"10.1016","volume":"30","author":[{"given":"Omid","family":"Veiseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest M.","family":"Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddy D.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2008.10.003_bib1","series-title":"World cancer report","author":"Stewart","year":"2003"},{"key":"10.1016\/j.biomaterials.2008.10.003_bib2","article-title":"SEER cancer statistics review, 1975\u20132005","author":"Ries","year":"2007"},{"issue":"22","key":"10.1016\/j.biomaterials.2008.10.003_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.gt.3303033","article-title":"Progress and prospects: gene therapy clinical trials (part 2)","volume":"14","author":"Alton","year":"2007","journal-title":"Gene Ther"},{"issue":"18","key":"10.1016\/j.biomaterials.2008.10.003_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-viral gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.10.003_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.gt.3302238","article-title":"Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes","volume":"11","author":"McNeish","year":"2004","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.biomaterials.2008.10.003_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tibtech.2005.12.002","article-title":"Cancer gene-therapy: clinical trials","volume":"24","author":"Palmer","year":"2006","journal-title":"Trends Biotechnol"},{"issue":"6648","key":"10.1016\/j.biomaterials.2008.10.003_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/38410","article-title":"Gene therapy - promises, problems and prospects","volume":"389","author":"Verma","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biomaterials.2008.10.003_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.biomaterials.2008.10.003_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jgm.1100","article-title":"Gene therapy clinical trials worldwide to 2007-an update","volume":"9","author":"Edelstein","year":"2007","journal-title":"J Gene Med"},{"issue":"3","key":"10.1016\/j.biomaterials.2008.10.003_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/bit.21541","article-title":"Library selection and directed evolution approaches to engineering targeted viral vectors","volume":"98","author":"Jang","year":"2007","journal-title":"Biotechnol Bioeng"},{"issue":"18","key":"10.1016\/j.biomaterials.2008.10.003_bib11","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2174\/092986706777935276","article-title":"The features and shortcomings for gene delivery of current non-viral carriers","volume":"13","author":"Kodama","year":"2006","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.10.003_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nmat1645","article-title":"Polymers for gene delivery across length scales","volume":"5","author":"Putnam","year":"2006","journal-title":"Nat Mater"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.10.003_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/156652305774964749","article-title":"Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies","volume":"5","author":"Ohlfest","year":"2005","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.biomaterials.2008.10.003_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg1577","article-title":"Towards safe, non-viral therapeutic gene expression in humans","volume":"6","author":"Glover","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.biomaterials.2008.10.003_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1359-6446(02)02243-2","article-title":"Targeting tumors with non-viral gene delivery systems","volume":"7","author":"Ogris","year":"2002","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.biomaterials.2008.10.003_bib16","first-page":"S7","article-title":"Targeting tumors with non-viral gene delivery systems","volume":"5","author":"Wagner","year":"2003","journal-title":"J Gene Med"},{"issue":"9","key":"10.1016\/j.biomaterials.2008.10.003_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"10.1016\/j.biomaterials.2008.10.003_bib18","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture\u00a0and in-vivo - polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2008.10.003_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(99)00090-5","article-title":"Poly(ethylenimine) and its role in gene delivery","volume":"60","author":"Godbey","year":"1999","journal-title":"J Controlled Release"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2008.10.003_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-3659(01)00513-2","article-title":"Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine","volume":"79","author":"Benns","year":"2002","journal-title":"J Controlled Release"},{"issue":"7","key":"10.1016\/j.biomaterials.2008.10.003_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jgm.382","article-title":"Integrin targeting using RGD-PEI conjugates for in vitro gene transfer","volume":"5","author":"Kunath","year":"2003","journal-title":"J Gene Med"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.10.003_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/bc970098f","article-title":"In vitro gene delivery to hepatocytes with galactosylated polyethylenimine","volume":"8","author":"Zanta","year":"1997","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.biomaterials.2008.10.003_bib23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.biomaterials.2006.11.015","article-title":"Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons","volume":"28","author":"Zeng","year":"2007","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2008.10.003_bib24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/bc0601119","article-title":"Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors","volume":"17","author":"Germershaus","year":"2006","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.biomaterials.2008.10.003_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jconrel.2004.03.019","article-title":"Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin (R)) conjugated polyethylemmine","volume":"97","author":"Chiu","year":"2004","journal-title":"J Controlled Release"},{"issue":"14","key":"10.1016\/j.biomaterials.2008.10.003_bib26","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a Chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biomaterials.2008.10.003_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.biomaterials.2008.10.003_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/smll.200700784","article-title":"In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes","volume":"4","author":"Sun","year":"2008","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.biomaterials.2008.10.003_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/nl0502569","article-title":"Optical and MRI multifunctional nanoprobe for targeting gliomas","volume":"5","author":"Veiseh","year":"2005","journal-title":"Nano Lett"},{"issue":"2","key":"10.1016\/j.biomaterials.2008.10.003_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-0890-4","article-title":"Radiation dosimetry of I-131-chlorotoxin for targeted radiotherapy in glioma-bearing mice","volume":"71","author":"Shen","year":"2005","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.biomaterials.2008.10.003_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/10010034","article-title":"Polymers for DNA delivery","volume":"10","author":"Eliyahu","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2008.10.003_bib32","series-title":"Polymer therapeutics: polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities. Polymer therapeutics I: polymers as drugs, conjugates and gene delivery systems","author":"Duncan","year":"2006"},{"issue":"12","key":"10.1016\/j.biomaterials.2008.10.003_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"issue":"14","key":"10.1016\/j.biomaterials.2008.10.003_bib34","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.addr.2006.09.008","article-title":"Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity","volume":"58","author":"Hunter","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2008.10.003_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1740925X06000044","article-title":"A role for ion channels in glioxna cell invasion","volume":"2","author":"McFerrin","year":"2006","journal-title":"Neuron Glia Biol"},{"issue":"18","key":"10.1016\/j.biomaterials.2008.10.003_bib36","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1021\/ma012060a","article-title":"Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers","volume":"35","author":"Petersen","year":"2002","journal-title":"Macromolecules"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208007771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208007771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:07:31Z","timestamp":1758899251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961208007771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0142961208007771"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.10.003","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}